Translation
EnglishDeutsch

Pinnacle Professors

Volume and Transactions Increase YoY on TSX Venture

Mrz 31st, 2017 | By brinvest | Category: Pinnacle Professors

TSX Venture investing remains a challenging experience for many, despite the exchange remaining in a robust bull market since bottoming in January of 2016. One only has to look at the volume and value of that volume to understand the tidal wave of liquidity that has come back to Canada’s junior exchange.   TMX Group Consolidated Trading Statistics for the TSX Venture – February 2017 TSX Venture transactions in 2016image source: http://www.tsx.com/resource/en/1474   The year-to-date statistics are even more ... [more]



Canabo Opens Clinic in London, Ontario and Announces Plans to Release its First Observational Research Study

Mrz 30th, 2017 | By brinvest | Category: Pinnacle Professors

Canabo Medical Inc. (TSX VENTURE: CMM) (OTCQB: CAMDF) (“Canabo” or the “Company”) is pleased to announce it has opened its 15th clinic in London, Ontario. The London clinic is located at 130 Thompson Road. Canabo is also pleased to announce that Dr. Neil Smith, Executive Chairman will be presenting results from the Company’s Observational Study at the Canadian Consortium for the Investigation of Cannabinoids (CCIC) “Cannabinoids in Clinical Practice” event April 6-7, 2017 in Toronto. The research to be presented will ... [more]



Molori Energy Continues Multi-Month Run

Mrz 30th, 2017 | By brinvest | Category: Pinnacle Professors

Molori Energy (MOL: TSXV) has been among the best performing junior oil and gas stocks on the TSX Venture since late-2016. After bottoming out in early October at $0.055 per share, Molori closed at a new all-time high of $0.43 Wednesday. The company’s shares moved 21.13% higher on solid volume. Molori has not had any huge volume days in the past months, but instead inches higher on between 50,000 and 200,000 shares traded daily.   Molori Energy – 6 Month Chart [more]



Has China Discovered World’s Largest Gold Mine?

Mrz 29th, 2017 | By brinvest | Category: Pinnacle Professors

Gold demand in China has been relentless in recent years and shows no signs of slowing. Unlike countries in the west, China produces as much as it can and buys every ounce it can get it hands on. When it comes to business and the acquisition of wealth, China is known for taking the long run. When the price of gold suffered after peaking in 2011, it was China buying up many assets throughout the years before gold finally bottomed ... [more]



Dios Exploration | Another Junior Quietly Moving Higher

Mrz 29th, 2017 | By brinvest | Category: Pinnacle Professors

Dios Exploration (DOS: TSXV) had another strong day in the markets, rising 10.53% on nearly 100,000 shares traded Tuesday.   Dios Exploration – 6 Month Chart Dios Exploration   It is sometimes surprising to see how quietly junior mining stocks can creep higher. Dios is up more than 80% from its low of $0.06 hit in late 2016.   Dios Exploration Hits Mineralized Zones   Dios Exploration’s latest press release, titled Several tens of meter mineralized zones in DIOS’ first holes of winter drilling program ... [more]



Minaurum Gold Continues Rally in 2017

Mrz 28th, 2017 | By brinvest | Category: Pinnacle Professors

Minaurum Gold (MGG: TSXV) jumped 13.4% on over 350,000 shares traded to capture the Daily Stock Challenge Breakout award Monday. Gold is surging and many junior gold stocks have broken out to new highs in recent sessions. Minaurum Gold is no exception and has been on an epic rally since January when it traded below $0.10 per share.   Minaurum Gold – 3 Month Chart Minaurum Gold After looking into the company’s leadership, Minaurum Gold’s current run is not surprising ... [more]



Darnley Bay Announces Filing of NI 43-101 Technical Report, Appoints Community Relations Manager

Mrz 27th, 2017 | By brinvest | Category: Pinnacle Professors

Darnley Bay Resources Limited (TSX VENTURE:DBL) (“Darnley Bay” or the “Company”) has filed a Technical Report on the Pine Point Project, NWT, further to the Company’s press release of March 4, 2017. The report was prepared in accordance with National Instrument 43-101 – Standards for Disclosure for Mineral Projects and has been filed on the issuer’s profile on SEDAR. Based on drilling and other work from previous operators, the resources cover 15 of the 60 known historical deposits on the ... [more]



Canadian Orebodies Mobilizes Drill to Hemlo North Limb Property

Mrz 24th, 2017 | By brinvest | Category: Pinnacle Professors

Canadian Orebodies Inc. (“Orebodies” or the “Company”) (TSX VENTURE:CORE) is pleased to announce that a Phase 1 drill program of 2,500 metres will be commencing on the Company’s North Limb Property in early April.

“We are excited to commence drilling in the next few weeks on our North Limb Property as we believe it has great underexplored potential. The ‘Tongue’ portion of the Property is particularly interesting, as it is interpreted to be the up ice potential source of the high
... [more]



Canadian Orebodies Mobilizes Drill to Hemlo North Limb Propert

Mrz 23rd, 2017 | By brinvest | Category: Pinnacle Professors

Canadian Orebodies Inc. (“Orebodies” or the “Company”) (TSX VENTURE:CORE) is pleased to announce that a Phase 1 drill program of 2,500 metres will be commencing on the Company’s North Limb Property in early April.

“We are excited to commence drilling in the next few weeks on our North Limb Property as we believe it has great underexplored potential. The ‘Tongue’ portion of the Property is particularly interesting, as it is interpreted to be the up ice potential source of the high
... [more]



Pulmatrix’s Stock Jumps 39% After EU Patent

Mrz 22nd, 2017 | By brinvest | Category: Pinnacle Professors

This morning, Pulmatrix announced it received European patent for its inhaled drug delivery technology. The biotech stock soared 39% to close at $3.88 per share on 22.8 million shares traded. Today marks the second time in March Pulmatrix has been awarded the Daily Stock Challenge Breakout award. We notified investors on March 17th after Pulmatrix’s stock gapped up 32%. In Pulmatrix Moves Higher One Week After Financials, we wrote,

“Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address
... [more]